Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, Bajaj B, Vedamurthy M, Sheikh S, Mittal R. Prasad S, et al. Among authors: mittal r. Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):459-67. doi: 10.4103/0378-6323.98077. Indian J Dermatol Venereol Leprol. 2012. PMID: 22772617 Free article. Clinical Trial.
A clinical trial to assess the immunogenicity and safety of Inactivated Influenza Vaccine (Whole Virion) IP (Pandemic Influenza (H1N1) 2009 Monovalent Vaccine; VaxiFlu-S™) in healthy Indian adult population.
Kubavat AH, Mittal R, Patel PM, Jarsaniya DH, Pawar PR; H1N1 2009 Vaccine Study Group. Kubavat AH, et al. Among authors: mittal r. J Postgrad Med. 2011 Apr-Jun;57(2):102-8. doi: 10.4103/0022-3859.81860. J Postgrad Med. 2011. PMID: 21654130 Clinical Trial.
A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
Kubavat AH, Khippal N, Tak S, Rijhwani P, Bhargava S, Patel T, Shah N, Kshatriya RR, Mittal R. Kubavat AH, et al. Among authors: mittal r. Am J Ther. 2013 Mar-Apr;20(2):154-62. doi: 10.1097/MJT.0b013e318254259b. Am J Ther. 2013. PMID: 22926233 Clinical Trial.
Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial.
Bhavsar B, Choksi B, Sanmukhani J, Dogra A, Haq R, Mehta S, Mukherjee S, Subramanian V, Sheikh S, Mittal R. Bhavsar B, et al. Among authors: mittal r. J Clin Diagn Res. 2014 Aug;8(8):YC05-9. doi: 10.7860/JCDR/2014/9111.4769. Epub 2014 Aug 20. J Clin Diagn Res. 2014. PMID: 25302253 Free PMC article.
Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.
Sood A, Mitra M, Joshi HA, Nayak US, Siddaiah P, Babu TR, Mahapatro S, Sanmukhani J, Gupta G, Mittal R, Glueck R. Sood A, et al. Among authors: mittal r. Hum Vaccin Immunother. 2017 Jul 3;13(7):1523-1530. doi: 10.1080/21645515.2017.1302629. Epub 2017 Mar 31. Hum Vaccin Immunother. 2017. PMID: 28362563 Free PMC article. Clinical Trial.
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial.
Sharma S, Singh VB, Kumar S, Prajapati V, Patel J, Vukkala R, Jangid SK, Sanmukhani J, Gupta G, Patel P, Mittal R, Glueck R. Sharma S, et al. Among authors: mittal r. Hum Vaccin Immunother. 2018 Jun 3;14(6):1362-1369. doi: 10.1080/21645515.2018.1441654. Epub 2018 Mar 21. Hum Vaccin Immunother. 2018. PMID: 29461913 Free PMC article. Clinical Trial.
A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months.
Kothari K, Shah S, Gill VK, Ray RK, Kumar NR, Sanmukhani J, Daultani P, Mittal R, Dutta T, Mahajan M, Desai S. Kothari K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2416329. doi: 10.1080/21645515.2024.2416329. Epub 2024 Oct 24. Hum Vaccin Immunother. 2024. PMID: 39445787 Free PMC article. Clinical Trial.
1,630 results